Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@TinaWitte Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::404283686.png) @TinaWitte Tina Witte

Tina Witte posts on X about regulatory, sales forecast, tariffs, $4523t the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::404283686/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404283686/c:line/m:interactions.svg)

- X Week XXX +309%
- X Month XXX +783%
- X Months XXXXX +51%
- X Year XXXXX +270%

### Mentions: X [#](/creator/twitter::404283686/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404283686/c:line/m:posts_active.svg)

- X Week XX +257%
- X Month XX +575%
- X Months XX +152%
- X Year XX +227%

### Followers: XXX [#](/creator/twitter::404283686/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404283686/c:line/m:followers.svg)

- X Week XXX no change
- X Month XXX no change
- X Months XXX -X%
- X Year XXX -XXXX%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::404283686/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404283686/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::404283686/influence)
---

**Social category influence**
[finance](/list/finance)  XXX% [stocks](/list/stocks)  XXX%

**Social topic influence**
[regulatory](/topic/regulatory) 3.7%, [sales forecast](/topic/sales-forecast) 3.7%, [tariffs](/topic/tariffs) 3.7%, [$4523t](/topic/$4523t) XXX%

**Top accounts mentioned or mentioned by**
[@fwpharma](/creator/undefined) [@fwhealthtech](/creator/undefined) [@mobihealthnews](/creator/undefined) [@biopharmadive](/creator/undefined)
### Top Social Posts [#](/creator/twitter::404283686/posts)
---
Top posts by engagements in the last XX hours

"FDA weighs regulatory action on argenx's Vyvgart Hytrulo amid reports of 'severe worsening' of disease"  
![@TinaWitte Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404283686.png) [@TinaWitte](/creator/x/TinaWitte) on [X](/post/tweet/1941831801489469743) 2025-07-06 12:09:13 UTC XXX followers, XX engagements


"J&J weathers Stelara downturn tariffs and raises annual sales forecast again via @fwpharma"  
![@TinaWitte Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404283686.png) [@TinaWitte](/creator/x/TinaWitte) on [X](/post/tweet/1945823456680894525) 2025-07-17 12:30:38 UTC XXX followers, XX engagements


"Eisai adopts Elix Discovery to accelerate AI-driven drug development via @fwpharma"  
![@TinaWitte Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404283686.png) [@TinaWitte](/creator/x/TinaWitte) on [X](/post/tweet/1947253005406912869) 2025-07-21 11:11:09 UTC XXX followers, XX engagements


"Citing lack of evidence FDA panel votes against Otsuka's PTSD programme via @fwpharma"  
![@TinaWitte Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404283686.png) [@TinaWitte](/creator/x/TinaWitte) on [X](/post/tweet/1947252732101890111) 2025-07-21 11:10:04 UTC XXX followers, XX engagements


"Merck KGaA gets EU nod for SpringWorks' neurofibromas drug via @fwpharma"  
![@TinaWitte Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404283686.png) [@TinaWitte](/creator/x/TinaWitte) on [X](/post/tweet/1947256450113208521) 2025-07-21 11:24:50 UTC XXX followers, XXX engagements


"Neurocrine Biosciences Presents New Analysis of CAHtalog Registry Showing Most Patients with Classic Congenital Adrenal Hyperplasia Experienced High Glucocorticoid Exposure Suboptimal Disease Control or Both at ENDO 2025"  
![@TinaWitte Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404283686.png) [@TinaWitte](/creator/x/TinaWitte) on [X](/post/tweet/1945475829414166597) 2025-07-16 13:29:17 UTC XXX followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@TinaWitte Avatar @TinaWitte Tina Witte

Tina Witte posts on X about regulatory, sales forecast, tariffs, $4523t the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXX +309%
  • X Month XXX +783%
  • X Months XXXXX +51%
  • X Year XXXXX +270%

Mentions: X #

Mentions Line Chart

  • X Week XX +257%
  • X Month XX +575%
  • X Months XX +152%
  • X Year XX +227%

Followers: XXX #

Followers Line Chart

  • X Week XXX no change
  • X Month XXX no change
  • X Months XXX -X%
  • X Year XXX -XXXX%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence finance XXX% stocks XXX%

Social topic influence regulatory 3.7%, sales forecast 3.7%, tariffs 3.7%, $4523t XXX%

Top accounts mentioned or mentioned by @fwpharma @fwhealthtech @mobihealthnews @biopharmadive

Top Social Posts #


Top posts by engagements in the last XX hours

"FDA weighs regulatory action on argenx's Vyvgart Hytrulo amid reports of 'severe worsening' of disease"
@TinaWitte Avatar @TinaWitte on X 2025-07-06 12:09:13 UTC XXX followers, XX engagements

"J&J weathers Stelara downturn tariffs and raises annual sales forecast again via @fwpharma"
@TinaWitte Avatar @TinaWitte on X 2025-07-17 12:30:38 UTC XXX followers, XX engagements

"Eisai adopts Elix Discovery to accelerate AI-driven drug development via @fwpharma"
@TinaWitte Avatar @TinaWitte on X 2025-07-21 11:11:09 UTC XXX followers, XX engagements

"Citing lack of evidence FDA panel votes against Otsuka's PTSD programme via @fwpharma"
@TinaWitte Avatar @TinaWitte on X 2025-07-21 11:10:04 UTC XXX followers, XX engagements

"Merck KGaA gets EU nod for SpringWorks' neurofibromas drug via @fwpharma"
@TinaWitte Avatar @TinaWitte on X 2025-07-21 11:24:50 UTC XXX followers, XXX engagements

"Neurocrine Biosciences Presents New Analysis of CAHtalog Registry Showing Most Patients with Classic Congenital Adrenal Hyperplasia Experienced High Glucocorticoid Exposure Suboptimal Disease Control or Both at ENDO 2025"
@TinaWitte Avatar @TinaWitte on X 2025-07-16 13:29:17 UTC XXX followers, XX engagements

@TinaWitte
/creator/twitter::TinaWitte